KLR Investment Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$349K Sell
5,564
-618
-10% -$38.1K 0.25% 117
2023
Q4
$351K Buy
+6,182
New +$324K 0.25% 120
2023
Q3
Sell
-5,303
Closed -$357K 179
2023
Q2
$357K Buy
+5,303
New +$323K 0.29% 115

Other funds holding LMAT

KLR Investment Advisors's LMAT Position: Q1 2024 in Review

KLR Investment Advisors reduced its LeMaitre Vascular (LMAT) stake by 10% in Q1 2024, selling an estimated $38.1K and leaving 5,564 shares worth $349K. The position accounts for 0.25% of the portfolio, ranked #117.

KLR Investment Advisors first reported a position in LMAT in Q2 2023 and has held it in 3 quarters since. The position peaked at $357K in Q2 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.

  • KLR Investment Advisors held 5,564 shares of LeMaitre Vascular worth $349K as of Q1 2024.
  • KLR Investment Advisors sold 618 LeMaitre Vascular shares in Q1 2024, an estimated $38.1K.
  • LeMaitre Vascular made up 0.25% of KLR Investment Advisors's portfolio in Q1 2024, its #117 holding.
  • KLR Investment Advisors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 3 quarters since.
  • KLR Investment Advisors's LeMaitre Vascular position peaked at $357K in Q2 2023.
  • 243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.

Based on KLR Investment Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.